Wednesday, December 23, 2009

AstraZeneca's French Connection

AstraZeneca has agreed to acquire Novexel, in a deal that adds to its pipeline of potential new drugs to tackle infections. The deal centers on Paris-based Novexel's two most advanced drug-development programs, CAZ104 and CEF104.

No comments: